Title: Karen Barnwell, Auditor
1Common Audit Findings
- Karen Barnwell, Auditor
- Office of Research Compliance
-
2Regulations Considered During an Audit
- 21 CFR 50 Protection of Human Subjects
- 21 CFR 56 Institutional Review Boards
- 21 CFR 312 Investigational New Drug Application
- 45 CFR 46 Protection of Human Subjects
- ICH E6 Good Clinical Practice Consolidated
Guidance - IRB Standard Operating Policies Procedures
- IRB Investigators Handbook
- http//www.fda.gov
- Code of Federal Regulations or Guidance Documents
- under Reference Room
- http//www.uams.edu/irb/IRB.asp
3UAMS Common Findings
- Informed Consent
- Protocol Deviations/Violations
- Study Records
- IRB
4Common FDA Audit Findings
- Inadequate Informed Consent
- Failure to Adhere to Protocol
- Inadequate/Incorrect Records
- Failure to Notify IRB of Changes
- Use of Unapproved Concomitant Meds
- Problems with Record Availability
- Failure to Obtain IRB Approval
- Failure to Obtain Informed Consent
- (These are from inspections through 4/5/04)
5INFORMED CONSENT
6Informed Consent Findings
- No PI Signature/Stamped Signature
- Dates Missing/Incomplete/Different
- Times Incomplete Too Much Time Between
Signatures - Missing Informed Consent Forms
- Informed Consent Process Documentation
7Informed Consent Process
- ..No investigator may involve a human being as a
subject in research unless the investigator has
obtained the legally effective informed consent
of the subject or the subjects legally
authorized representative. An investigator shall
seek such consent only under circumstances that
provide the prospective subject or the
representative sufficient opportunity to consider
whether or not to participate and that minimize
the possibility of coercion or undue influence.
The information that is given to the subject or
the representative shall be in language
understandable to the subject or the
representative - 45 CFR 46.116
8Steps in Informed Consent Process
- Starts with an interview
- Is an exchange of essential information about the
research - Allows an opportunity for participant to ask
questions and have them answered - Is evidenced by the signing of informed consent
document - Is documented in record
- Requires giving a copy of the Informed Consent
form to the participant - Continues at each interaction by providing the
participant new information as it develops
9Who Does the IC Interview?
- Who can conduct the Interview to obtain Informed
Consent? - The PI
- A sub-investigator
- A study staff person, listed with the IRB, whom
the investigator has documented is fully
conversant with the study and is able to answer
participants questions
10The Informed Consent Document
- Use the current, IRB approved version
11Informed Consent Document
- The ICD should
- Contain all required elements
- Describe the study in language the person can
understand - Be signed, dated and timed by
- Subject or Legally Authorized Representative
(LAR) - Witness
- Investigator
- Person obtaining the consent
- The person signing as the witness cannot be the
same as the person obtaining consent or the
investigator
12PROTOCOL DEVIATIONS/VIOLATIONS
13 21 CFR 312.60General responsibilities of
investigators.
-
- An investigator is responsible for ensuring that
an investigation is conducted according to the
signed investigator statement, the
investigational plan, and applicable regulations
14Protocol Findings
- Inclusion/Exclusion Criteria
- Very Detailed Protocol Blood Samples, Blood
Tests, Phone Calls, Sites of Procedures - Dates/Times of Protocol Required Procedures
- Randomization Procedure
15Research?Medical Practice
16Patients vs. Participants
- When a person volunteers for a research trial,
he/she has become a participant. - Participants may not be receiving standard of
care as a patient. The risks may be higher - Documentation for participants is more extensive
than regular patient documentation
17STUDY RECORDS
18Study Record Findings
- Source Data Not Available/Not Signed or Dated
- Data Changes Made Incorrectly
- Signature Logs
- Study Staff Responsibility Chart
- CVs Outdated/Missing
- Licenses Expired/Missing
- HSP/HIPAA Training Missing
19I.R.B.
20IRB Findings
- CR Expired
- Protocol Deviations/Violations Not Reported
- SAEs/AEs Not Reported or Reported Late
- Use of Unapproved Material
- Approved Accrual Goal Exceeded
- Study Personnel Not Up-To-Date/Incomplete
- Incomplete IRB Files Missing IRB
Correspondence/Other
21IRB Investigators Handbook
- Chapter 8 - Research Record-Keeping and Reporting
- ARIA Information
- Record-Keeping Responsibilities Of The Principal
Investigator (PI) - Investigators Responsibilities For Test Article
Accountability - Subject Information Regarding Investigational
Drugs Or Devices - Investigator IRB Reporting Responsibilities
- Change in Principal Investigator
- Communicating With Subjects
- Reporting Responsibilities Of The Principal
Investigator To The IRB - Adverse Event Reporting
- How To Report A Death Or Serious Adverse Event
- Reporting Protocol Deviations
- Reporting Protocol Violations
- Reporting Notification Of Pending Audits Or
Inquiries - Reporting to Appropriate Federal Oversight
Bodies, Institutional Officials and Research
Sponsors - Changing Study Protocol/Modifications to
Previously Approved Research
22An ounce of prevention is worth a pound of cure!
OR
23Slay your dragons before they slay you!